Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice
- 30 September 2007
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 35 (9), 1366-1375
- https://doi.org/10.1016/j.exphem.2007.05.022
Abstract
No abstract availableKeywords
Funding Information
- Lauri Strauss Leukemia Foundation
- National Institutes of Health (K-23CA087977-03)
This publication has 29 references indexed in Scilit:
- 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significanceCancer Genetics and Cytogenetics, 2006
- Characterization of familial Waldenström's macroglobulinemiaAnnals of Oncology, 2005
- Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.Blood, 2005
- Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral bloodBlood, 2004
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemiaSeminars in Oncology, 2003
- Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletionsBlood, 2002
- Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch eventsBlood, 2002
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994